Litcius/Paper detail

Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer

Steven E. Schild, Xiaofei Wang, Christine M. Bestvina, Terence M. Williams, Greg Masters, Anurag Kumar Singh, Thomas E. Stinchcombe, Joseph K. Salama, Steven Wolf, Tyler Zemla, Narjust Duma, Stephen G. Chun, Arya Amini, David Kozono, Colleen Watt

2022Clinical Lung Cancer18 citationsDOIOpen Access PDF

Topics & Concepts

MedicineLung cancerImmunotherapyOncologyInternal medicineSystemic therapyRandomized controlled trialCancerBreast cancerCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Treatments and Mutations
Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer | Litcius